Sleep Disorders

Experts continue to explore connections between sleep health and neurological disorders, as well as technology for measuring patients’ sleep.

Lucie Barateau, MD, assistant professor of neurology, Hôpital Gui De Chauliac, offered insight on the usefulness of the newly developed pediatric narcolepsy type 1 severity scale.

The associate professor of neurology at Washington University in St. Louis discussed how developing programs focused on sleep health are a step to increasing awareness and understanding its integral role in overall well-being.

Raman Malhotra, MD, associate professor of neurology at Washington University in St. Louis, commented on the importance of sleep education, particularly for younger generations.

Raman Malhotra, MD, associate professor of neurology at Washington University in St. Louis, discussed the importance inquiring about patients’ sleep, as well as the dangers of insufficient sleep.

Here's what is coming soon to NeurologyLive.

Associate professor of neurology at Washington University in St. Louis discussed returning to normalcy following the COVID-19 pandemic and the nascent effects experts have seen on sleep health.

Neurology News Network for the week ending July 10, 2021.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 9, 2021.

The study was conducted at Wright-Patterson Air Force Base to examine the effect of fatigue on cognition and mood within the military population.  

Raman Malhotra, MD, associate professor of neurology at Washington University in St. Louis, detailed a new position statement from AASM on the vitality of sleep.

The original Narcolepsy Severity Scale was reformulated with the driving-related item removed to assess a pediatric version for the school-aged and adolescent narcolepsy type 1 population.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending July 2, 2021.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 2, 2021.

The differences between the obstructive sleep apnea categories became more apparent when a shorter epoch-to-epoch interval was used to assess this deep learning-based signal.

Data presented at SLEEP 2021 from Study 303 suggest that long-term use of lemborexant is well received by patients, who reported that the agent helped them fall asleep and improved total sleep time.

Here's what is coming soon to NeurologyLive.

The calcium, magnesium, potassium, and sodium oxybates oral solution, marketed as Xywav, is currently also under review for the treatment of idiopathic hypersomnia, with an FDA decision expected by August 12, 2021.

We kindly ask you to share 5 minutes of your time with us in order to help us better understand how you use social media and how we can better serve you across different platforms.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 25, 2021.

Calli L. Cook, NP, DNP, nurse practitioner, Woodruff School of Nursing, Emory University, detailed her vision for creating change within the neurology field by incorporating advanced practice clinicians.

Michael J. Thorpy, MD, director of the Sleep-Wake Disorders Center at Montefiore Medical Center, discussed how telemedicine has factored in the care for patients with sleep disorders throughout the pandemic.

The medical director of the Ohio State Sleep Medicine Institute provided insight on areas within sleep disorder care that need improvement, including the diagnostic process.

The Idorsia dual orexin receptor antagonist was accepted by the FDA for review in March 2021 and has shown efficacy in a number of SLEEP 2021 poster presentations.